Since the parental anti-hHER2 antibody of [fam-] trastuzumab deruxtecan does not bind to mouse ERBB2, we prepared a mouse cell line that stably expresses the human target gene [21–23] and used those cells to construct an immunocompetent mouse tumor model. Here, ERBB2 is linked to neoplasm.